Bictegravir (INN, BIC, formerly known as GS-9883) is an antiviral drug of the integrase inhibitor class that was structurally derived from an earlier compound dolutegravir by scientists at Gilead Sciences. Reference standards of Bictegravir API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
(S)-3,9-Dihydroxy-2-((1S,3R)-3-hydroxycyclopentyl)-1,8-dioxo-N-(2,4,6-trifluorobenzyl)-1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide
Catalogue No.:PA 02 1911000
CAS :
Molecular Formula : C21H20F3N3O6
Molecular Weight : 467.4
(R)-3,9-Dihydroxy-2-((1S,3R)-3-hydroxycyclopentyl)-1,8-dioxo-N-(2,4,6-trifluorobenzyl)-1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide
Catalogue No.:PA 02 1911001
(2R,5S)-8-Hydroxy-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine 6,12-dioxide
Catalogue No.:PA 02 1911002
Molecular Formula : C21H18F3N3O7
Molecular Weight : 481.38
Bictegravir
Catalogue No.:PA 02 1910000
Molecular Formula : C21H18F3N3O5
Molecular Weight : 449.39
(2S,5R,13aS)-8-Hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
Catalogue No.:PA 02 1911003
(2R,5R,13aR)-8-Hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
Catalogue No.:PA 02 1911004
(2R,5S,13aR)-8-Methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
Catalogue No.:PA 02 1911005
Molecular Formula : C22H20F3N3O5
Molecular Weight : 463.41
(2R,5S,13aR)-N-(2,4-Difluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
Catalogue No.:PA 02 1911006
Molecular Formula : C21H19F2N3O5
Molecular Weight : 431.4
(2S,5R,13aS)-N-(2-Fluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
Catalogue No.:PA 02 1911007
Molecular Formula : C21H20FN3O5
Molecular Weight : 413.41
(2S,5R,13aS)-N-(4-Fluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
Catalogue No.:PA 02 1911008
(2S,5R,13aS)-N-(2,6-Difluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
Catalogue No.:PA 02 1911009
1-(2,2-Dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid
Catalogue No.:PA 02 1911010
Molecular Formula : C13H17NO8
Molecular Weight : 315.28
(2S,3S,4S,5R,6S)-6-(((2R,5S,13aR)-7,9-Dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Catalogue No.:PA 02 1911011
Molecular Formula : C27H26F3N3O11
Molecular Weight : 625.51
Bictegravir-13C-15N-d2
Catalogue No.:PA STI 089238
Molecular Formula : C2013CH16D2F3N215NO5
Molecular Weight : 453.38
9-Hydroxy-2-((1S,3R)-3-hydroxycyclopentyl)-1,8-dioxo-N-(2,4,6-trifluorobenzyl)-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide
Catalogue No.:PA 02 1911012
(2R,5S,13aR)-8-Hydroxy-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine 6,12-dioxide
Catalogue No.:PA 02 1911013
Bictegravir D4
Catalogue No.:PA STI 089828
Molecular Formula : C21H14D4F3N3O5
Molecular Weight : 453.41
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
